Protocol 
A Phase I trial of B7- trans f ected lethally irradiated allogeneic 
melanoma cell lines to induce cell-mediated immunity against tumor- 
associated antigen presented by HLA-A2 or HLA-A1 in patients with stage 
IV melanoma 
NCI Protocol T93-0161 
BRMP Protocol 9401 
Principal Investigator: 
Protocol Chairman: 
Associate Investigators: 
Mario Sznol, M.D 
Robert Fenton, M.D., Ph.D 
Barry Gause, M.D. 
John Janik, M.D. 
Dennis Taub, Ph.D. 
Dan Longo, M.D. 
Bill Kopp, Ph.D. 
Karen Madara, R.N. 
BRMP physicians 
October 6, 1993 3:00pm 
Recombinant DNA Research, Volume 18 
[719] 
